HIV Protease Inhibitors and Obesity

Current Opinion in Endocrinology, Diabetes and Obesity - United States
doi 10.1097/med.0b013e32833dde87
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

HIV Protease Inhibitors and Mortality Following Kidney Transplantation

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2018English

HIV-protease Inhibitors for the Treatment of Cancer: Repositioning HIV Protease Inhibitors While Developing More Potent NO-hybridized Derivatives?

International Journal of Cancer
Cancer ResearchOncology
2017English

Anti-Hiv Drugs and Resistance: Inhibitors of HIV-1 Reverse Transcriptase and Protease

2012English

Pharmacokinetic Interactions Between Cyclosporine and Protease Inhibitors in HIV + Subjects

Drug Metabolism and Pharmacokinetics
PharmacologyPharmaceutical Science
2003English

Molecular Recognition of Cyclic Urea HIV-1 Protease Inhibitors

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

HIV Gag and PR: Partners in Resistance to Protease and Maturation Inhibitors

Retrovirology
VirologyInfectious Diseases
2011English

Antimalarial Asexual Stage-Specific and Gametocytocidal Activities of HIV Protease Inhibitors

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2009English

Counteracting Akt Activation by HIV Protease Inhibitors in Monocytes/Macrophages

Viruses
VirologyInfectious Diseases
2018English

HIV-protease Inhibitors Block the Enzymatic Activity of Purified Ste24p

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy